Li Zhang

发表

Soy Protein With Isoflavones, but not an Isoflavone-Rich Supplement, Improves Arterial Low-Density Lipoprotein Metabolism and Atherogenesis

R. Blair, J. D. Wagner, M. Anthony, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys

J. D. Wagner, T. Clarkson, T. Register, 2002, Menopause.

Effects of Mammalian and Plant Estrogens on Lipoprotein Metabolism and Coronary Heart Disease

J. D. Wagner, K. Greaves, D. Schwenke, 2000 .

Effects of Short-term Hormone Replacement Therapies on Low-Density Lipoprotein Metabolism in Cynomolgus Monkeys

J. D. Wagner, M. Adams, J. Bagdade, 1997 .

High isoflavone soy diet increases insulin secretion without decreasing insulin sensitivity in premenopausal nonhuman primates.

J. D. Wagner, K. L. Jones, D. Flynn, 2008, Nutrition research.

Short-term hyperglycemia increases arterial superoxide production and iron dysregulation in atherosclerotic monkeys.

J. D. Wagner, P. Rowe, K. Kavanagh, 2011, Metabolism: clinical and experimental.

Estrogen Decreases Atherosclerosis in Part by Reducing Hepatic Acyl-CoA:Cholesterol Acyltransferase 2 (ACAT2) in Monkeys

J. D. Wagner, M. Adams, L. Rudel, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Secoisolariciresinol Diglucoside Regulates Adipose Tissue Metabolic Disorder in Obese Mice Induced by a Western Diet

Li Zhang, Shan Dong, Wenliang Bai, 2021, Journal of Food Quality.

Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue.

M. Anthony, K. Kavanagh, M. Shadoan, 2007, Metabolism: clinical and experimental.

Effects of soy vs. casein protein on body weight and glycemic control in female monkeys and their offspring

J. Cline, J. Kaplan, A. Franke, 2009, American journal of primatology.

Epigenetic Changes with Dietary Soy in Cynomolgus Monkeys

G. Hawkins, M. Medvedovic, S. Ho, 2011, PloS one.

A Selective Peroxisome Proliferator-Activated Receptor α Agonist, CP-900691, Improves Plasma Lipids, Lipoproteins, and Glycemic Control in Diabetic Monkeys

O. Francone, L. Royer, B. Auerbach, 2010, Journal of Pharmacology and Experimental Therapeutics.

A Selective Cannabinoid-1 Receptor Antagonist, PF-95453, Reduces Body Weight and Body Fat to a Greater Extent than Pair-Fed Controls in Obese Monkeys

B. Auerbach, K. Kavanagh, H. J. Harwood, 2010, Journal of Pharmacology and Experimental Therapeutics.

Effects of hormone therapy on insulin signaling proteins in skeletal muscle of cynomolgus monkeys

M. Shadoan, Li Zhang, J. Wagner, 2004, Steroids.

Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys.

D. Flynn, K. Kavanagh, Li Zhang, 2011, American journal of physiology. Endocrinology and metabolism.

Ongoing b -Cell Turnover in Adult Nonhuman Primates Is Not Adaptively Increased in Streptozotocin-Induced Diabetes

C. Cobelli, G. Toffolo, P. Butler, 2011 .

Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys.

M. Adams, J. Kaplan, Haiying Chen, 2008, Metabolism: clinical and experimental.

Ongoing β-Cell Turnover in Adult Nonhuman Primates Is Not Adaptively Increased in Streptozotocin-Induced Diabetes

C. Cobelli, G. Toffolo, P. Butler, 2011, Diabetes.

Characterization and validation of a streptozotocin-induced diabetes model in the vervet monkey.

D. Flynn, K. Kavanagh, Li Zhang, 2011, Journal of pharmacological and toxicological methods.

Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator-activated receptor-gamma agonist use in prediabetes.

Mandy L Berquist, K. Brown, K. Kavanagh, 2010, Metabolism: clinical and experimental.

Diabetes and Obesity Research using Nonhuman Primates

H. J. Harwood, J. Cann, Li Zhang, 2012 .

Characterization and Heritability of Obesity and Associated Risk Factors in Vervet Monkeys

L. Fairbanks, L. Rudel, J. Bailey, 2007, Obesity.

Tissue-specific regulation and expression of heat shock proteins in type 2 diabetic monkeys

K. Kavanagh, Li Zhang, J. Wagner, 2009, Cell Stress and Chaperones.

Rosiglitazone treatment improves insulin regulation and dyslipidemia in type 2 diabetic cynomolgus monkeys.

S. E. Rankin, R. Kauffman, Li Zhang, 2004, Metabolism: clinical and experimental.

Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys.

W. Cefalu, J. D. Wagner, M. Anthony, 1997, Metabolism: clinical and experimental.

A Selective Cannabinoid-1 Receptor Antagonist, PF-95453, Reduces Body Weight and Body Fat to a Greater Extent than Pair-Fed Controls in Obese Monkeys

K. Kavanagh, J. Hadcock, Li Zhang, 2010, Journal of Pharmacology and Experimental Therapeutics.

Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys.

J. D. Wagner, L. Zhang, T. Clarkson, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys

C. Cobelli, G. Toffolo, P. Butler, 2009, Diabetologia.